RHYTHM PHARMACEUTICALS, INC.

Rhythm Pharmaceuticals (RYTM) shows zero cyber incidents and zero red-flag 8-K filings in our 90-day monitoring window, indicating a clean recent compliance record. However, low signal in a recent window does not mean low risk—the company's longer-term financial health, capital structure, and pipeline execution require deeper analysis. The full $49 Report extends coverage to 12 months of SEC filings, calculates dilution risk from equity raises and warrant exercises, contextualizes all 8-K events, and flags AI-detected early warning signals in financing patterns and officer activity. The full $49 Report adds dilution trajectory, historical financing risk score, 12-month 8-K narrative, and predictive risk signals.